and as soon as practicable a computer-based system for data reduction will be developed so as to extract from the morbidity (or 'event') records information to maintain an ongoing medical summary for each patient. This process will be based on the principle of linking 'event' records into groups of entries relating to 'episodes of illness'.
Experimental developments will be evaluated in each situation so as to detect, and where possible quantify, their effects on practice function. Baseline information will be obtained by performing an 'initial state evaluation' in each participating practice, particular attention being given to the work patterns of medical and ancillary staff, and to the records system used. Subsequent changes in staff work patterns will be monitored by means of constructing an 'activities profile' for each practice from data obtained on sample days. A specially designed day sheet has been used for this purpose in pilot studies and has been found to be satisfactory. In addition to monitoring the direct effects of experimental innovations, evaluation by this means is expected to detect secondary or unforeseen effects on practice functions which might otherwise pass unnoticed. The evidence was reviewed from observations in man for the hypothesis that cancer results from a breakdown in immunological surveillance allowing the proliferation of an abnormal clone of cells with a selective advantage over other cells. There are several rare immunological disorders in which malignancy, particularly of the reticuloendothelial system, occurs more commonly than in the general population. However, these may have a common cause and evaluation is difficult. Similarly comparisons with regard to malignancy between man and animals after thymectomy in the neonatal period are not possible. This operation is not usually performed in this period, and the rare congenital absence of the thymus is not compatible with survival into adult life. Certainly there is so far no suggestion that thymectomy in man after the neonatal period is followed by any increased risk of cancer.
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Of great interest is the increased frequency of reticulum cell sarcoma in the immunosuppressed recipients of renal transplants. A crucial question for the concept of immunosurveillance in regard to neoplastic disease is whether intensive immunosuppression will lead to an increased frequency of cancers other than reticuloses. It is hoped that an answer to this question will come from a study currently being undertaken from Oxford with the help of the Cancer Research Campaign. This involves a long-term follow up of patients with renal transplants and also those with the nephrotic syndrome, rheumatoid arthritis, Crohn's disease and other medical disorders treated with azathioprine, chlorambucil, cyclophosphamide or methotrexate. The data presented in this paper were obtained as part of the Oxford Survey of Childhood Cancers, in which cases are ascertained by means of cancer registrations and death certificates. Information subsequently collected from general practitioners and hospitals provides data for the calculation of survival rates and the study of the natural history of these diseases. Ascertainment of deaths will be nearly complete, but because cancer registration is incomplete there will be certain biases in the data, e.g. survival rates will be underestimated, but this should not affect the general nature of the conclusions presented here. The analysis is based on 335 cases of Wilms's tumour diagnosed below the age of 10 years in England and Wales during 1962-66. The general background to the study has been described by Ledlie et al. (1970) . The main object of this paper is to consider the problem of tumour progression by examining relationships
